Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 16Leukemia 13Lymphoma 11Graft vs Host Disease 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Follicular 4Hodgkin Disease 4Waldenstrom Macroglobulinemia 3Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Myelodysplastic-Myeloproliferative Diseases 2Multiple Myeloma 2Lymphoma, T-Cell, Peripheral 2Kidney Neoplasms 2Hematologic Neoplasms 2Carcinoma, Renal Cell 2Bronchiolitis Obliterans Syndrome 2Stomach Neoplasms 1Pancreatic Neoplasms 1Myeloproliferative Disorders 1Mycosis Fungoides 1Mesothelioma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Leukemia, Prolymphocytic 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

Pemetrexed 23Cisplatin 19Nivolumab 8Gemcitabine 7Ipilimumab 6Carboplatin 6pembrolizumab 4Bevacizumab 4tazemetostat 3durvalumab 3Fluorouracil 3Drug Therapy 3spartalizumab 2olaparib 2niraparib 2budigalimab 2belinostat 2anetumab ravtansine 2amatuximab 2Vinorelbine 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2PM 01183 2Oxaliplatin 2Imatinib Mesylate 2Everolimus 2Erlotinib Hydrochloride 2Doxorubicin 2Cyclophosphamide 2venetoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mesothelioma × Pentostatin × Clear all
NCT01362790 2019-06-06

SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
55 enrolled 22 charts
GastrointestinalOther solid neoplasmThoracic

Adenocarcinoma of Lung, Mesothelioma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡